Fiber fix for peanut allergy? small study tests prebiotic boost to OIT

NCT ID NCT05138757

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small pilot study tested whether adding a prebiotic fiber (a type of plant fiber found in grocery stores) to peanut oral immunotherapy could help children aged 4 to 17 with peanut allergy tolerate more peanut protein with fewer side effects. Twenty children participated, and the study looked at safety and how many could eat at least 2044 mg of peanut protein with only mild symptoms after 12 months. The results are preliminary and need larger studies to confirm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
prebiotic fiber
What this could lead to
If it works, this could point toward a way to make peanut oral immunotherapy safer and more effective by adding a simple dietary fiber.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply broadly. The prebiotic is not FDA-approved for this use, and side effects like stomach issues are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Comer Children's Hospital

    Chicago, Illinois, 60637, United States

  • University of Chicago- Department of Pediatrics

    Hyde Park, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.